[文献资料]参 考 文 献

Identification of driver mutations in tumor specimens from 1000 patients with lung adenocarcinoma：The NCI s Lung Cancer Mutation Consortium（LCMC）. J，Clin Oncol，2012，29（suppl）：477s，abstr CRA7506 .LUX-Lung 3：A randomized，open-label，phase Ⅲ study of afatinib ......